Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : June 26, 2015 2:40 PM IST
Now you may soon find relief from migraine headaches as a new class of drugs is in the works to cure the pain. The medications work to inhibit the release of CGRP that is found to be elevated during migraine headache attacks and returns to normal when headaches are resolved, ExamHealth reported. Learn how to spot migraine symptoms.
They would prevent migraine headaches before they start. Professor Thomas Ward at Dartmouth in New Hampshire excitedly explained that it would be highly effective for people who have not a had an effective treatment. Read: Natural remedies for migraine
Researchers say medications that block CGRP entirely could have a negative impact on the body's organs. The new class of drugs use monoclonal antibodies to target CGRP release that causes blood vessels to dilate and become inflamed.
Alder Pharmaceuticals, Amgen, Eli Lilly and Company, and Teva Pharmaceuticals are in the process of testing the drugs that could bring relief for a substantial number of migraine headache sufferers with minimal side effects. An injection could be taken once a month to stop headaches from developing. Read: 8 yoga asanas to help relieve a migraine headache
It should be noted that the findings are preliminary.
Source: ANI
Image source: Getty Images
For more articles on diseases & conditions, visit our diseases & conditions section. For daily free health tips, sign up for our newsletter.
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.